The Effect of Deafferentation on Cerebral Blood Flow Response to Acetazolamide

American Journal of Neuroradiology

Volumn 25, Issue 1, 2004, Pages 92-96

  Yamauchi, Hiroshi ^a,b   Okazawa, Hidehiko ^a   Sugimoto, Kanji ^a   Kishibe, Yoshihiko ^a   Takahashi, Masaaki ^a  

^a Shiga Medical Center   (Japan)

^b SHIGA MEDICAL CENTER FOR ADULTS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTICLE; AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN INFARCTION; BRAIN METABOLISM; BRAIN PERFUSION; CEREBELLUM; CLINICAL ARTICLE; CROSSED CEREBELLAR DIASCHISIS; DEAFFERENTATION; FEMALE; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PERFUSION PRESSURE; POSITRON EMISSION TOMOGRAPHY; VASODILATATION;

ACETAZOLAMIDE; AGED; BLOOD VOLUME; CARBONIC ANHYDRASE INHIBITORS; CEREBELLAR CORTEX; CEREBRAL CORTEX; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; STATISTICS; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATION;

EID: 1642541664     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vorstrup S. Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test. Acta Neurol Scand Suppl 1988;114:1-48
2. Yonas H, Pindzola RR. Physiological determination of cerebrovascular reserves and its use in clinical management. Cerebrovasc Brain Metab Rev. 1994;6:325-340
3. Yonas H, Smith HA, Durham SR, et al. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483-489
4. Kuroda S, Houkin K, Kamiyama H, et al. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110-2116
5. Ogasawara K, Ogawa A, Terasaki K, et al. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab 2002;22:1142-1148
6. Nariai T, Suzuki R, Hirakawa K, et al. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron-emission tomography. AJNR Am J Neuroradiol 1995;16:563-570
7. Yamauchi H, Okazawa H, Kishibe Y, et al. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease. Eur J Nucl Med 2002;29:1349-1356
8. Gotoh F, Meyer JS, Tomita M. Carbonic anhydrase inhibition and cerebral venous blood gases and ions in man. Arch Intern Med 1966;117:39-46
9. Garcia JH, Lassen NA, Weiller C, et al. Ischemic stroke and incomplete infarction. Stroke 1996;27:761-765
10. Feeney DM, Baron JC. Diaschisis. Stroke 1986;17:817-830
11. Baron JC, Bousser MG, Comar D, Castaigne P. Crossed cerebellar diaschisis in human supratentorial brain infarction. Trans Am Neurol Assoc 1980;105:459-461
12. Yamauchi H, Fukuyama H, Kimura J. Hemodynamic and metabolic changes in crossed cerebellar hypoperfusion. Stroke 1992;23:855-860
13. DeGardo T, Turkington T, Williams J, et al. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-1406
14. 15O gas and water. J Cereb Blood Flow Metab 2001;21:793-803
15. Okazawa H, Yamauchi H, Sugimoto K, et al. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001;21:1472-1479
16. Votaw JR, Shulman SD. Performance evaluation of the pico-count flow-through detector for use in cerebral blood flow PET studies. J Nucl Med 1998;39:509-515
17. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980;4:727-736
18. Lammertsma AA, Jones T. Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain. I. Description of the method. J Cereb Blood Flow Metab 1983;3:416-424
19. Herscovitch P, Markham J, Raichle ME. Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. J Nucl Med 1983;24:782-789
20. Raichle ME, Martin WRW, Herscovitch P, et al. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. J Nucl Med 1983;24:790-798
21. Bogsrud TV, Rootwelt K, Russell D, Nyberg-Hansen R. Acetazolamide effect on cerebellar blood flow in crossed cerebral-cerebellar diaschisis. Stroke 1990;21:52-55
22. Matsuda H, Tsuji S, Sumiya H, et al. Acetazolamide effect on vascular response in areas with diaschisis as measured by Tc-99m HMPAO brain SPECT. Clin Nucl Med 1992;17:581-586
23. Sakashita Y, Matsuda H, Kakuda K, Takamori M. Hypoperfusion and vasoreactivity in the thalamus and cerebellum after stroke. Stroke 1993;24:84-87
24. 15O-H2O positron emission tomography. Eur J Nucl Med 1996;23:683-689
25. Ito H, Kanno I, Shimosegawa E, et al. Hemodynamic changes during neuronal deactivation in human brain: a positron emission tomography study of crossed cerebellar diaschisis. Ann Nucl Med 2002;16:249-254
26. Dong Y, Fukuyama H, Nabatame H, et al. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease: a comparison with PET study. Stroke 1997;28:1776-1782